Director

Jeff Ross is CEO of Miromatrix, a Minnesota-based biotechnology company dedicated to the bioengineering of whole organs. Dr. Ross received both his MS in Biomedical Engineering and PhD in Molecular, Cellular and Developmental Biology from the University of Minnesota.

Dr. Ross has held various positions at Guidant, Athersys, and SurModics for the development and commercialization of numerous bio-based therapies. At Miromatrix, he has led the commercialization of perfusion decellularization, from early research through good manufacturing practices (GMP) manufacturing and Food and Drug Administration (FDA) approval, resulting in the launch of Miromatrix’s first products.

He has over 30 published and issued patents along with leading publications in Nature and the Journal of Clinical Investigation.